RAC supplies reference standards for 6 Medetomidine impurities, including Medetomidine Impurity 11 and Medetomidine Impurity 14. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| Padrão | CAS | Status | |
|---|---|---|---|
| Medetomidine Impurity 11 | 5724-56-1 | EM SÍNTESE | |
| Medetomidine Impurity 14 | 30595-81-4 | EM SÍNTESE | |
| Medetomidine Impurity 39 | 67478-50-6 | EM SÍNTESE | |
| Medetomidine Impurity 80 | 55968-40-6 | EM SÍNTESE | |
| Medetomidine Impurity 81 | 86347-35-5 | EM SÍNTESE | |
| Medetomidine Impurity 82 | 51270-91-8 | EM SÍNTESE |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI nitrosamines and degradation products of Medetomidine that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.